OBJECTIVE: The current review study summarizes the pathogenic mechanism of DNM3OS in various pathophysiological processes, aiming to reveal its important value as a therapeutic drug target for related human diseases and provide a new way for targeted therapy.
METHODS: Through systematic retrieval and in-depth study of relevant articles in PubMed, this article analyzes and summarizes the pathogenic roles and molecular mechanisms in pathophysiological processes of long non-coding RNA DNM3OS.
RESULTS: DNM3OS exerts an important regulatory role in the occurrence and development of bone diseases, neoplastic diseases, fibrotic diseases, inflammatory diseases, and many other diseases.
CONCLUSIONS: DNM3OS is a potential new biomarker and therapeutic target for the treatment of a series of diseases, consisting of bone diseases, neoplastic diseases, fibrotic diseases, and inflammatory diseases.
目的:本综述综述了DNM3OS在各种病理生理过程中的致病机制。旨在揭示其作为人类相关疾病治疗药物靶点的重要价值,为靶向治疗提供新的途径。
方法:通过对PubMed中相关文章的系统检索和深入研究,本文就长链非编码RNADNM3OS在病理生理过程中的致病作用和分子机制进行分析和总结。
结果:DNM3OS在骨病的发生发展过程中发挥着重要的调节作用,肿瘤疾病,纤维化疾病,炎症性疾病,和许多其他疾病。
结论:DNM3OS是治疗一系列疾病的潜在新生物标志物和治疗靶点,由骨骼疾病组成,肿瘤疾病,纤维化疾病,和炎症性疾病。